Status:
WITHDRAWN
Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Contraception
Eligibility:
FEMALE
18-35 years
Phase:
PHASE1
Brief Summary
Levonorgestrel/ethinyl estradiol (LNG/EE) is an investigational drug that is being developed as an oral contraceptive (birth control pill). The purpose of this trial is to compare different preparatio...
Eligibility Criteria
Inclusion
- Women aged 18 to 35 years.
- Healthy as determined by the investigator on the basis of medical history and screening evaluations.
- Must have a history of normal menstrual cycles (24 to 34 days) for the 3-month period preceding entry into the study.
Exclusion
- Any surgical or medical condition that may interfere with the absorption, distribution, metabolism, or excretion of the test article.
- Presence, history, or family history of thrombophlebitis, thrombosis, or thromboembolitic disorders, deep vein thrombosis, pulmonary embolism, or known coagulopathy.
- Bethesda system report of low-grade squamous intraepithelial lesion or greater for a cervical cytologic smear obtained within the last 3 months.
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00447863
Start Date
August 1 2007
End Date
August 1 2007
Last Update
August 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.